CliffBio
small molecule

APOKYN

APOMORPHINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyMDD US OPERATIONS, LLC →See this company's full patent-cliff portfolio

Drug detail

Brand nameAPOKYN
Active ingredientAPOMORPHINE HYDROCHLORIDE
Strength20MG/2ML (10MG/ML)
Dosage formINJECTABLE
RouteSUBCUTANEOUS
ModalitySmall molecule
FDA approvalApril 2004
Marketing statusDISCN

More from MDD US OPERATIONS, LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

APOKYN patent cliff — loss of exclusivity — | CliffBio